Main Menu

Longevity Acquisition Corporation

(NASDAQ GS: LOAC)

Rigrodsky Law, P.A. is investigating Longevity Acquisition Corporation (“Longevity”) regarding possible breaches of fiduciary duties and other violations of law related to Longevity's agreement to merge with 4D Pharma PLC ("4D Pharma"). Under the terms of the agreement, Longevity’s shareholders will receive 7.5315 ordinary shares of 4D Pharma for each share of Longevity they own.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 01/21/2021


* Indicates a required field.

Back to Page